$ASNS Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in X4 Pharmaceuticals, Inc.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in X4 Pharmaceuticals, Inc. Get notifications about new insider transactions in X4 Pharmaceuticals, Inc for free.

Page:   1 2 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 02 2021ASNSX4 Pharmaceuticals ...Bridger GaryDirectorOption ExerciseA9.506,00057,0006,000
Jun 02 2021ASNSX4 Pharmaceuticals ...Aliski WilliamDirectorOption ExerciseA9.506,00057,0006,000
May 04 2021ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.332,40019,992412,752415.2 K to 412.8 K (-0.58 %)
Apr 07 2021ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS9.172,40022,008415,152417.6 K to 415.2 K (-0.57 %)
Feb 03 2021ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS7.882,40018,912275,323277.7 K to 275.3 K (-0.86 %)
Jan 06 2021ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS7.002,40016,800277,723280.1 K to 277.7 K (-0.86 %)
Jan 06 2021ASNSX4 Pharmaceuticals ...Cadavid DiegoChief Medical Offic ...Option ExerciseA6.43121,500781,245121,500
Dec 28 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS7.004,80033,600280,123284.9 K to 280.1 K (-1.68 %)
Dec 01 2020ASNSX4 Pharmaceuticals ...Taveras ArthurChief Scientific Of ...Option ExerciseA6.60121,150799,590121,150
Oct 21 2020ASNSX4 Pharmaceuticals ...Stewart MurrayDirectorOption ExerciseA7.2710,00072,70010,000
Oct 06 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS7.001,79712,579284,923286.7 K to 284.9 K (-0.63 %)
Oct 06 2020ASNSX4 Pharmaceuticals ...Lawton Alison FrancesDirectorOption ExerciseA7.336,85450,2406,854
Sep 22 2020ASNSX4 Pharmaceuticals ...Mostafa Adam S.Chief Financial Off ...SellS7.0810,83476,70529,58940.4 K to 29.6 K (-26.80 %)
Sep 10 2020ASNSX4 Pharmaceuticals ...Skerlj RenatoChief Scientific Of ...SellS8.055,83446,96442,07647.9 K to 42.1 K (-12.18 %)
Sep 10 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.048,84071,074287,323296.2 K to 287.3 K (-2.98 %)
Sep 10 2020ASNSX4 Pharmaceuticals ...Meisner Derek MGeneral CounselSellS8.058,33467,08916,66625 K to 16.7 K (-33.34 %)
Sep 03 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS7.992,40019,176296,163298.6 K to 296.2 K (-0.80 %)
Aug 18 2020ASNSX4 Pharmaceuticals ...Mostafa Adam S.Chief Financial Off ...GrantA0.0016,250040,42324.2 K to 40.4 K (+67.22 %)
Aug 18 2020ASNSX4 Pharmaceuticals ...Mostafa Adam S.Chief Financial Off ...GrantA0.0016,250024,1737.9 K to 24.2 K (+205.10 %)
Aug 18 2020ASNSX4 Pharmaceuticals ...Skerlj RenatoChief Scientific Of ...GrantA0.008,750047,91039.2 K to 47.9 K (+22.34 %)
Aug 18 2020ASNSX4 Pharmaceuticals ...Skerlj RenatoChief Scientific Of ...GrantA0.008,750039,16030.4 K to 39.2 K (+28.77 %)
Aug 18 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOGrantA0.0044,8250298,563253.7 K to 298.6 K (+17.67 %)
Aug 18 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOGrantA0.0044,8260253,738208.9 K to 253.7 K (+21.46 %)
Aug 18 2020ASNSX4 Pharmaceuticals ...Meisner Derek MGeneral CounselGrantA0.0012,500025,00012.5 K to 25 K (+100.00 %)
Aug 18 2020ASNSX4 Pharmaceuticals ...Meisner Derek MGeneral CounselGrantA0.0012,500012,5000 to 12.5 K
Aug 04 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS7.452,40017,880208,912211.3 K to 208.9 K (-1.14 %)
Jul 06 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS9.052,40021,720211,312213.7 K to 211.3 K (-1.12 %)
Jul 01 2020ASNSX4 Pharmaceuticals ...Mostafa Adam S.See RemarksPayment of ExerciseF9.329168,5377,9238.8 K to 7.9 K (-10.36 %)
Jul 01 2020ASNSX4 Pharmaceuticals ...Mostafa Adam S.See RemarksSellS9.041,72515,5948,83910.6 K to 8.8 K (-16.33 %)
Jun 11 2020ASNSX4 Pharmaceuticals ...Skerlj RenatoChief Scientific Of ...Option ExerciseA8.6950,000434,50050,000
Jun 11 2020ASNSX4 Pharmaceuticals ...Aliski WilliamDirectorOption ExerciseA8.693,42729,7813,427
Jun 11 2020ASNSX4 Pharmaceuticals ...Russo ReneDirectorOption ExerciseA8.693,42729,7813,427
Jun 11 2020ASNSX4 Pharmaceuticals ...WYZGA MICHAEL SDirectorOption ExerciseA8.693,42729,7813,427
Jun 11 2020ASNSX4 Pharmaceuticals ...Stewart MurrayDirectorOption ExerciseA8.693,42729,7813,427
Jun 11 2020ASNSX4 Pharmaceuticals ...MCGIRR DAVID W JDirectorOption ExerciseA8.693,42729,7813,427
Jun 11 2020ASNSX4 Pharmaceuticals ...Bridger GaryDirectorOption ExerciseA8.693,42729,7813,427
Jun 03 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.889,70786,198213,712223.4 K to 213.7 K (-4.34 %)
Jun 03 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.652,40020,760223,419225.8 K to 223.4 K (-1.06 %)
Jun 03 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.634,27536,893225,819230.1 K to 225.8 K (-1.86 %)
Jun 03 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.889,70786,198213,712223.4 K to 213.7 K (-4.34 %)
Jun 03 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.652,40020,760223,419225.8 K to 223.4 K (-1.06 %)
Jun 03 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.634,27536,893225,819230.1 K to 225.8 K (-1.86 %)
May 05 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.922,40021,408230,094232.5 K to 230.1 K (-1.03 %)
Apr 03 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS8.402,40020,160232,494234.9 K to 232.5 K (-1.02 %)
Mar 03 2020ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOSellS10.642,40025,536234,894237.3 K to 234.9 K (-1.01 %)
Nov 27 2019ASNSX4 Pharmaceuticals ...Meisner Derek MGeneral CounselOption ExerciseA11.0355,000606,65055,000
Sep 20 2019ASNSX4 Pharmaceuticals ...Aliski WilliamDirectorOption ExerciseA14.046,85496,2306,854
Sep 20 2019ASNSX4 Pharmaceuticals ...Aliski WilliamDirectorOption ExerciseA14.046,85496,2306,854
Jun 19 2019ASNSX4 Pharmaceuticals ...Russo ReneDirectorOption ExerciseA14.753,42750,5483,427
Jun 19 2019ASNSX4 Pharmaceuticals ...MCGIRR DAVID W JDirectorOption ExerciseA14.753,42750,5483,427
Jun 19 2019ASNSX4 Pharmaceuticals ...Mostafa Adam S.CFO and TreasurerOption ExerciseA14.7515,847233,74315,847
Jun 19 2019ASNSX4 Pharmaceuticals ...Mostafa Adam S.CFO and TreasurerGrantA0.0010,564010,5640 to 10.6 K
Jun 19 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOOption ExerciseA14.7583,8931,237,42283,893
Jun 19 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOGrantA0.0055,9280237,294181.4 K to 237.3 K (+30.84 %)
Apr 26 2019ASNSX4 Pharmaceuticals ...Kelley Lynne EChief Medical Offic ...Option ExerciseA20.3037,170754,55137,170
Apr 26 2019ASNSX4 Pharmaceuticals ...Kelley Lynne EChief Medical Offic ...Option ExerciseA20.3037,170754,55137,170
Apr 02 2019ASNSX4 Pharmaceuticals ...Stewart MurrayDirectorOption ExerciseA17.416,854119,3286,854
Mar 14 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOOption ExerciseA7.0880,160567,53380,160
Mar 14 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOOption ExerciseA6.8465,430447,54165,430
Mar 14 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOOption ExerciseA6.84100,729688,986100,729
Mar 14 2019ASNSX4 Pharmaceuticals ...Ragan PaulaPresident and CEOGrantA0.00181,3660181,3660 to 181.4 K
Mar 14 2019ASNSX4 Pharmaceuticals ...Bridger GaryDirectorOption ExerciseA10.4421,570225,19121,570
Mar 14 2019ASNSX4 Pharmaceuticals ...Bridger GaryDirectorOption ExerciseA10.4421,570225,19121,570
Mar 14 2019ASNSX4 Pharmaceuticals ...BLECH ISAACDirectorOption ExerciseA6.8470,796484,24570,796
Mar 14 2019ASNSX4 Pharmaceuticals ...BLECH ISAACDirectorOption ExerciseA6.8470,796484,24570,796
Mar 14 2019ASNSX4 Pharmaceuticals ...WYZGA MICHAEL SDirectorOption ExerciseA10.4470,324734,18370,324
Mar 14 2019ASNSX4 Pharmaceuticals ...WYZGA MICHAEL SDirectorOption ExerciseA10.4470,324734,18370,324
Mar 14 2019ASNSX4 Pharmaceuticals ...Mostafa Adam S.See RemarksOption ExerciseA10.4462,633653,88962,633
Mar 14 2019ASNSX4 Pharmaceuticals ...Mostafa Adam S.See RemarksOption ExerciseA10.4462,633653,88962,633
Nov 28 2018ASNSArsanis, Inc.GRAY MICHAELPresident, CEO and ...GrantA0.00250,0000250,0000 to 250 K
Nov 28 2018ASNSArsanis, Inc.GRAY MICHAELPresident, CEO and ...GrantA0.00250,0000250,0000 to 250 K
Jun 07 2018ASNSArsanis, Inc.MCGUIRE TERRANCEDirectorOption ExerciseA16.9910,000169,90010,000
Jun 07 2018ASNSArsanis, Inc.SCHULMAN AMY WDirectorOption ExerciseA16.9910,000169,90010,000
Jun 07 2018ASNSArsanis, Inc.Ross Michael JayDirectorOption ExerciseA16.9910,000169,90010,000
Jun 07 2018ASNSArsanis, Inc.Nessi ClaudioDirectorOption ExerciseA16.9910,000169,90010,000
Jun 07 2018ASNSArsanis, Inc.MCGIRR DAVID W JDirectorOption ExerciseA16.9910,000169,90010,000
Jun 07 2018ASNSArsanis, Inc.GORDON CARL LDirectorOption ExerciseA16.9910,000169,90010,000
Jun 07 2018ASNSArsanis, Inc.Gerngross Tillman U.DirectorOption ExerciseA16.9910,000169,90010,000
Jun 07 2018ASNSArsanis, Inc.Clark William DDirectorOption ExerciseA16.9910,000169,90010,000
Mar 09 2018ASNSArsanis, Inc.GRAY MICHAELCOO and CFOOption ExerciseA17.34110,0001,907,400110,000
Mar 09 2018ASNSArsanis, Inc.Mantus DavidChief Development O ...Option ExerciseA17.3450,000867,00050,000
Mar 09 2018ASNSArsanis, Inc.Russo RenePresident and CEOOption ExerciseA17.34160,0002,774,400160,000
Mar 09 2018ASNSArsanis, Inc.STEVENS ANTHONY CHRISChief Medical Offic ...Option ExerciseA17.3450,000867,00050,000
Dec 01 2017ASNSArsanis, Inc.Clark William DDirectorOption ExerciseA10.007,32473,2407,324
Dec 01 2017ASNSArsanis, Inc.Gerngross Tillman U.DirectorOption ExerciseA10.007,32473,2407,324
Dec 01 2017ASNSArsanis, Inc.GORDON CARL LDirectorOption ExerciseA10.007,32473,2407,324
Dec 01 2017ASNSArsanis, Inc.MCGUIRE TERRANCEDirectorOption ExerciseA10.007,32473,2407,324
Dec 01 2017ASNSArsanis, Inc.Ross Michael JayDirectorOption ExerciseA10.007,32473,2407,324
Dec 01 2017ASNSArsanis, Inc.Nessi ClaudioDirectorOption ExerciseA10.007,32473,2407,324
Dec 01 2017ASNSArsanis, Inc.SCHULMAN AMY WDirectorOption ExerciseA10.007,32473,2407,324
Dec 01 2017ASNSArsanis, Inc.MCGIRR DAVID W JDirectorOption ExerciseA10.007,32473,2407,324
Nov 20 2017ASNSArsanis, Inc.Bill & Melinda Gates Foundatio ...Option ExerciseC0.002,464,79900
Nov 20 2017ASNSArsanis, Inc.Bill & Melinda Gates Foundatio ...BuyC0.00722,1790722,1790 to 722.2 K
Nov 20 2017ASNSArsanis, Inc.NeoMed Innovation V L.P.10% OwnerOption ExerciseC0.00952,49700
Nov 20 2017ASNSArsanis, Inc.NeoMed Innovation V L.P.10% OwnerOption ExerciseC0.0084,04000
Nov 20 2017ASNSArsanis, Inc.NeoMed Innovation V L.P.10% OwnerOption ExerciseC0.00552,48700
Nov 20 2017ASNSArsanis, Inc.NeoMed Innovation V L.P.10% OwnerBuyP10.00300,0003,000,000867,639567.6 K to 867.6 K (+52.85 %)
Nov 20 2017ASNSArsanis, Inc.NeoMed Innovation V L.P.10% OwnerBuyC0.00279,0790567,639288.6 K to 567.6 K (+96.71 %)
Nov 20 2017ASNSArsanis, Inc.NeoMed Innovation V L.P.10% OwnerBuyC0.0041,8780288,560246.7 K to 288.6 K (+16.98 %)
Nov 20 2017ASNSArsanis, Inc.NeoMed Innovation V L.P.10% OwnerBuyC0.00246,6820246,6820 to 246.7 K
Nov 20 2017ASNSArsanis, Inc.EMBL Technology Fund II GmbH & ...10% OwnerOption ExerciseC0.00843,61300
Nov 20 2017ASNSArsanis, Inc.EMBL Technology Fund II GmbH & ...10% OwnerOption ExerciseC0.00207,25300
Nov 20 2017ASNSArsanis, Inc.EMBL Technology Fund II GmbH & ...10% OwnerBuyP10.0020,000200,000370,454350.5 K to 370.5 K (+5.71 %)
Nov 20 2017ASNSArsanis, Inc.EMBL Technology Fund II GmbH & ...10% OwnerBuyC0.00247,1760350,454103.3 K to 350.5 K (+239.33 %)
Nov 20 2017ASNSArsanis, Inc.EMBL Technology Fund II GmbH & ...10% OwnerBuyC0.00103,2780103,2780 to 103.3 K
Nov 20 2017ASNSArsanis, Inc.GV 2016 GP, L.L.C.10% OwnerOption ExerciseC0.001,540,49900
Nov 20 2017ASNSArsanis, Inc.GV 2016 GP, L.L.C.10% OwnerBuyC0.00451,3620451,3620 to 451.4 K
Nov 20 2017ASNSArsanis, Inc.Nessi ClaudioDirectorOption ExerciseC0.00952,49700
Nov 20 2017ASNSArsanis, Inc.Nessi ClaudioDirectorOption ExerciseC0.0084,04000
Nov 20 2017ASNSArsanis, Inc.Nessi ClaudioDirectorOption ExerciseC0.00552,48700
Nov 20 2017ASNSArsanis, Inc.Nessi ClaudioDirectorBuyP10.00300,0003,000,000867,639567.6 K to 867.6 K (+52.85 %)
Nov 20 2017ASNSArsanis, Inc.Nessi ClaudioDirectorBuyC0.00279,0790567,639288.6 K to 567.6 K (+96.71 %)
Nov 20 2017ASNSArsanis, Inc.Nessi ClaudioDirectorBuyC0.0041,8780288,560246.7 K to 288.6 K (+16.98 %)
Nov 20 2017ASNSArsanis, Inc.Nessi ClaudioDirectorBuyC0.00246,6820246,6820 to 246.7 K
Nov 20 2017ASNSArsanis, Inc.Anna-Maria & Stephen Kellen Fo ...10% OwnerOption ExerciseC0.00336,39300
Nov 20 2017ASNSArsanis, Inc.Anna-Maria & Stephen Kellen Fo ...10% OwnerOption ExerciseC0.0051,81300
Nov 20 2017ASNSArsanis, Inc.Anna-Maria & Stephen Kellen Fo ...10% OwnerBuyC0.0098,5620124,38125.8 K to 124.4 K (+381.74 %)
Nov 20 2017ASNSArsanis, Inc.Anna-Maria & Stephen Kellen Fo ...10% OwnerBuyC0.0025,819025,8190 to 25.8 K
Nov 20 2017ASNSArsanis, Inc.Section 32 Fund 1, LP10% OwnerOption ExerciseC0.001,540,50000
Nov 20 2017ASNSArsanis, Inc.Section 32 Fund 1, LP10% OwnerBuyC0.00451,3620451,3620 to 451.4 K
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.0050,47700
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.001,474,34800
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.0014,63500
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.00692,55200
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.004,74700
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.00224,66500
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.0015,24600
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.00721,40200
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.0014,58700
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.00690,25900
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.001,38000
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerOption ExerciseC0.0065,28700
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyP10.0016,552165,5201,868,9611.9 M to 1.9 M (+0.89 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyP10.00483,4484,834,4801,852,4091.4 M to 1.9 M (+35.31 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.0014,78901,368,9611.4 M to 1.4 M (+1.09 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.00431,98001,354,172922.2 K to 1.4 M (+46.84 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.004,2880922,192917.9 K to 922.2 K (+0.47 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.00202,9150917,904715 K to 917.9 K (+28.38 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.002,3650714,989712.6 K to 715 K (+0.33 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.00111,9550712,624600.7 K to 712.6 K (+18.64 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.006,8060600,669593.9 K to 600.7 K (+1.15 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.00322,1020593,863271.8 K to 593.9 K (+118.52 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.005,2190271,761266.5 K to 271.8 K (+1.96 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.00247,0100266,54219.5 K to 266.5 K (+1,264.64 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.00404019,53219.1 K to 19.5 K (+2.11 %)
Nov 20 2017ASNSArsanis, Inc.SVLSF V, LLC10% OwnerBuyC0.0019,128019,1280 to 19.1 K
Nov 20 2017ASNSArsanis, Inc.MCGUIRE TERRANCEDirectorOption ExerciseC0.0021,53700
Nov 20 2017ASNSArsanis, Inc.MCGUIRE TERRANCEDirectorOption ExerciseC0.0014,75200
Nov 20 2017ASNSArsanis, Inc.MCGUIRE TERRANCEDirectorOption ExerciseC0.0041,97600
Nov 20 2017ASNSArsanis, Inc.MCGUIRE TERRANCEDirectorOption ExerciseC0.002,153,74600

Page:   1 2 next >

Contact us | Follow us on Twitter